BACKGROUND: Coronavirus disease 2019 (COVID-19) causes a range of illness severity. Mild illness has been reported, but whether illness severity correlates with infectivity is unknown. We describe the public health investigation of a mildly ill, nonhospitalized COVID-19 case who traveled to China. METHODS: The case was a Maricopa County resident with multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive specimens collected on 22 January 2020. Contacts were persons exposed to the case on or after the day before case diagnostic specimen collection. Contacts were monitored for 14 days after last known exposure. High-risk contacts had close, prolonged case contact (≥ 10 minutes within 2 m). Medium-risk contacts wore all US Centers for Disease Control and Prevention-recommended personal protective equipment during interactions. Nasopharyngeal and oropharyngeal (NP/OP) specimens were collected from the case and high-risk contacts and tested for SARS-CoV-2. RESULTS: Paired case NP/OP specimens were collected for SARS-CoV-2 testing at 11 time points. In 8 pairs (73%), ≥ 1 specimen tested positive or indeterminate, and in 3 pairs (27%) both tested negative. Specimens collected 18 days after diagnosis tested positive. Sixteen contacts were identified; 11 (69%) had high-risk exposure, including 1 intimate contact, and 5 (31%) had medium-risk exposure. In total, 35 high-risk contact NP/OP specimens were collected for SARS-CoV-2 testing; all 35 pairs (100%) tested negative. CONCLUSIONS: This report demonstrates that SARS-CoV-2 infection can cause mild illness and result in positive tests for up to 18 days after diagnosis, without evidence of transmission to close contacts. These data might inform public health strategies to manage individuals with asymptomatic infection or mild illness. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
BACKGROUND:Coronavirus disease 2019 (COVID-19) causes a range of illness severity. Mild illness has been reported, but whether illness severity correlates with infectivity is unknown. We describe the public health investigation of a mildly ill, nonhospitalized COVID-19 case who traveled to China. METHODS: The case was a Maricopa County resident with multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive specimens collected on 22 January 2020. Contacts were persons exposed to the case on or after the day before case diagnostic specimen collection. Contacts were monitored for 14 days after last known exposure. High-risk contacts had close, prolonged case contact (≥ 10 minutes within 2 m). Medium-risk contacts wore all US Centers for Disease Control and Prevention-recommended personal protective equipment during interactions. Nasopharyngeal and oropharyngeal (NP/OP) specimens were collected from the case and high-risk contacts and tested for SARS-CoV-2. RESULTS: Paired case NP/OP specimens were collected for SARS-CoV-2 testing at 11 time points. In 8 pairs (73%), ≥ 1 specimen tested positive or indeterminate, and in 3 pairs (27%) both tested negative. Specimens collected 18 days after diagnosis tested positive. Sixteen contacts were identified; 11 (69%) had high-risk exposure, including 1 intimate contact, and 5 (31%) had medium-risk exposure. In total, 35 high-risk contact NP/OP specimens were collected for SARS-CoV-2 testing; all 35 pairs (100%) tested negative. CONCLUSIONS: This report demonstrates that SARS-CoV-2 infection can cause mild illness and result in positive tests for up to 18 days after diagnosis, without evidence of transmission to close contacts. These data might inform public health strategies to manage individuals with asymptomatic infection or mild illness. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Entities:
Keywords:
COVID-19; SARS-CoV-2; illness severity; serial testing; viral transmission
Authors: Fan-Yun Lan; Robert Filler; Soni Mathew; Jane Buley; Eirini Iliaki; Lou Ann Bruno-Murtha; Rebecca Osgood; Costas A Christophi; Alejandro Fernandez-Montero; Stefanos N Kales Journal: PLoS One Date: 2020-06-26 Impact factor: 3.240
Authors: Jason T Ladner; Brendan B Larsen; Jolene R Bowers; Crystal M Hepp; David M Engelthaler; Michael Worobey; Paul Keim; Evan Bolyen; Megan Folkerts; Krystal Sheridan; Ashlyn Pfeiffer; Hayley Yaglom; Darrin Lemmer; Jason W Sahl; Emily A Kaelin; Rabia Maqsood; Nicholas A Bokulich; Grace Quirk; Thomas D Watts; Kenneth K Komatsu; Victor Waddell; Efrem S Lim; J Gregory Caporaso Journal: mBio Date: 2020-09-04 Impact factor: 7.867
Authors: Kieran A Walsh; Karen Jordan; Barbara Clyne; Daniela Rohde; Linda Drummond; Paula Byrne; Susan Ahern; Paul G Carty; Kirsty K O'Brien; Eamon O'Murchu; Michelle O'Neill; Susan M Smith; Máirín Ryan; Patricia Harrington Journal: J Infect Date: 2020-06-29 Impact factor: 6.072
Authors: Victoria T Chu; Brandi Freeman-Ponder; Scott Lindquist; Christopher Spitters; Vance Kawakami; Jonathan W Dyal; Shauna Clark; Hollianne Bruce; Jeffrey S Duchin; Chas DeBolt; Sara Podczervinski; Marisa D'Angeli; Kristen Pettrone; Rachael Zacks; Grace Vahey; Michelle L Holshue; Misty Lang; Rachel M Burke; Melissa A Rolfes; Mariel Marlow; Claire M Midgley; Xiaoyan Lu; Stephen Lindstrom; Aron J Hall; Alicia M Fry; Natalie J Thornburg; Susan I Gerber; Satish K Pillai; Holly M Biggs Journal: Emerg Infect Dis Date: 2020-05-29 Impact factor: 6.883
Authors: Kamelia R Stanoeva; Annemiek A van der Eijk; Adam Meijer; Laetitia M Kortbeek; Marion P G Koopmans; Chantal B E M Reusken Journal: Euro Surveill Date: 2021-03